Olfen (Diclofenac Sodium, Lidocaine Hydrochloride)

Diclofenac sodium, the active ingredient in Olfen, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as a topical formulation for local pain relief use. It reduces inflammation and provides analgesia, often combined with a local anesthetic to enhance comfort in musculoskeletal conditions.

GNH USA supplies Olfen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olfen combines diclofenac sodium and lidocaine hydrochloride to address pain and inflammation in several musculoskeletal and dermatologic contexts. It is commonly employed for: - Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: alleviates inflammatory joint discomfort. - Acute musculoskeletal sprains and strains: provides rapid local pain relief. - Post‑operative wound pain: minimizes discomfort after minor surgical procedures. - Tendinitis and bursitis: eases inflammation and associated pain.

Adverse reactions to Olfen may vary in frequency and severity.

Common Side Effects: - Skin irritation at the application site: redness or itching. - Gastrointestinal discomfort: mild nausea or dyspepsia. - Headache: transient mild headache. - Dizziness: occasional light‑headed feeling.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Cardiovascular events: chest pain or signs of heart attack. - Liver enzyme elevation: abnormal liver function tests. - Blood disorders: unexplained bruising or bleeding.

When using Olfen, consider the following safety measures: - Assess cardiovascular risk: patients with heart disease may need monitoring. - Evaluate renal function: adjust use in patients with impaired kidney function. - Monitor gastrointestinal health: avoid in individuals with active ulcers. - Review concomitant NSAID use: limit combined NSAID exposure to reduce toxicity. - Pregnancy and lactation: avoid unless clearly indicated by a physician. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Olfen may interact with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Corticosteroids: additive risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors (e.g., enalapril): possible reduction in renal function. - Diuretics (e.g., furosemide): may enhance renal effects of NSAIDs. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.